Pharma-Bio Serv (PBSV) Equity Average (2016 - 2025)
Historic Equity Average for Pharma-Bio Serv (PBSV) over the last 15 years, with Q4 2025 value amounting to $11.9 million.
- Pharma-Bio Serv's Equity Average fell 1299.66% to $11.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $11.9 million, marking a year-over-year decrease of 1299.66%. This contributed to the annual value of $12.8 million for FY2025, which is 1411.61% down from last year.
- According to the latest figures from Q4 2025, Pharma-Bio Serv's Equity Average is $11.9 million, which was down 1299.66% from $12.0 million recorded in Q3 2025.
- In the past 5 years, Pharma-Bio Serv's Equity Average registered a high of $22.7 million during Q3 2021, and its lowest value of $11.9 million during Q4 2025.
- Its 5-year average for Equity Average is $16.3 million, with a median of $16.1 million in 2022.
- Its Equity Average has fluctuated over the past 5 years, first soared by 543.67% in 2021, then crashed by 2940.4% in 2022.
- Pharma-Bio Serv's Equity Average (Quarter) stood at $21.4 million in 2021, then decreased by 23.5% to $16.4 million in 2022, then dropped by 1.2% to $16.2 million in 2023, then fell by 15.2% to $13.7 million in 2024, then decreased by 13.0% to $11.9 million in 2025.
- Its Equity Average was $11.9 million in Q4 2025, compared to $12.0 million in Q3 2025 and $12.1 million in Q2 2025.